News
CFMS
--
0.00%
--
3 Medical Equipment Stocks Under $10 to Buy Now
StockNews.com · 1d ago
Is It Too Late To Consider Buying Conformis, Inc. (NASDAQ:CFMS)?
While Conformis, Inc. ( NASDAQ:CFMS ) might not be the most widely known stock at the moment, it saw a significant...
Simply Wall St. · 09/09 10:41
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participat...
GlobeNewswire · 09/07 21:00
Stonepine Capital Management, LLC Buys Amryt Pharma PLC, CTI BioPharma Corp, Chiasma Inc, Sells ...
GuruFocus News · 08/24 15:38
Return on Capital Employed Overview: Conformis
After pulling data from Benzinga Pro it seems like during Q2, Conformis (NASDAQ:CFMS) earned $30.89 million, a 437.8% increase from the preceding quarter. Conformis also posted a total of $56.35 million in sales, a 307.29% increase since Q1.
Benzinga · 08/20 17:59
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system.   Identity Imprint, available in both cruciate retaining (CR) and posterior
Benzinga · 08/18 21:00
This Just In: Analysts Are Boosting Their Conformis, Inc. (NASDAQ:CFMS) Outlook for This Year
Conformis, Inc. ( NASDAQ:CFMS ) shareholders will have a reason to smile today, with the analysts making substantial...
Simply Wall St. · 08/10 05:19
26 Stocks Moving in Thursday's Pre-Market Session
Gainers
Benzinga · 08/05 11:00
Conformis Q2 Earnings Surpass Estimates On Higher Volumes And Royalties, License Revenue
Benzinga · 08/05 10:52
ConforMIS Swings to Q2 Profit as Revenue Climbs; Shares Rise Pre-Bell
MT Newswires · 08/05 05:28
ConforMIS (CFMS) Surpasses Q2 Earnings and Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of 162.50% and 43.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 22:25
BRIEF-Conformis Q2 Earnings Per Share $0.21
reuters.com · 08/04 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Benzinga · 08/04 20:36
Conformis Reports Second Quarter 2021 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2021.
GlobeNewswire · 08/04 20:05
-- Earnings Flash (CFMS) CONFORMIS Posts Q2 Revenue $56.3M, vs. Street Est of $33M
MT Newswires · 08/04 16:23
ATVI, MGM and MNKD among pre market gainers
BeyondSpring BYSI +336% Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment of 2nd/3rd Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild Type
Seekingalpha · 08/04 12:40
A Preview Of Conformis's Earnings
On Wednesday, August 04, Conformis (NASDAQ:CFMS) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Benzinga · 08/03 15:07
Stocks That Hit 52-Week Highs On Monday
    Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.
Benzinga · 08/02 14:08
BRIEF-Conformis - On July 28, FDA Determined That It Appears Co Addressed Violations Contained In Dec 2019 Warning Letter
reuters.com · 07/30 21:39
ConforMIS (CFMS) Earnings Expected to Grow: Should You Buy?
Zacks.com · 07/28 19:03
Webull provides a variety of real-time CFMS stock news. You can receive the latest news about ConforMIS through multiple platforms. This information may help you make smarter investment decisions.
About CFMS
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.